Diagnosis and Management of Acquired Pure Red Cell Aplasia

Hematology/Oncology Clinics of North America

Volumn 23, Issue 2, 2009, Pages 249-259

  Sawada, Kenichi ^a   Hirokawa, Makoto ^b   Fujishima, Naohito ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

Corticosteroids; Cyclophosphamide; Cyclosporine; Diagnosis; Management; Pure red cell aplasia

Indexed keywords

CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; THYMOCYTE ANTIBODY;

DISEASE ASSOCIATION; ERYTHROCYTE APLASIA; HUMAN; MEDICAL ASSESSMENT; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; PARVOVIRUS; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PURE RED CELL ANEMIA; REVIEW; SPLENECTOMY; T LYMPHOCYTE; THYMOMA;

ADRENAL CORTEX HORMONES; CYCLOPHOSPHAMIDE; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RED-CELL APLASIA, PURE;

EID: 62649122397     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.01.009     Document Type: Review

References (45)

1. Dessypris E.N. Pure red cell aplasia. London (1988), The Johns Hopkins University Press, Baltimore (MD) p. 41-113
2. Dessypris E.N., and Lipton J.M. Red cell aplasia. In: Greer J.P., Foerster J., Lukens J.N., et al. (Eds). Wintrobe's clinical hematology. 11th edition (2004), Lippincott Williams & Wilkins, Philadelphia 1421-1427
3. Brown K.E., Anderson S.M., and Young N.S. Erythrocyte P antigen: cellular receptor for parvovirus B19. Science 262 5130 (1993) 114-117
4. Ramratnam B., Gollerkeri A., Schiffman F.J., et al. Management of persistent B19 parvovirus infection in AIDS. Br J Haematol 91 1 (1995) 90-92
5. Abkowitz J.L., Powell J.S., Nakamura J.M., et al. Pure red cell aplasia: response to therapy with anti-thymocyte globulin. Am J Hematol 23 4 (1986) 363-371
6. Charles R.J., Sabo K.M., Kidd P.G., et al. The pathophysiology of pure red cell aplasia: implications for therapy. Blood 87 11 (1996) 4831-4838
7. Lacy M.Q., Kurtin P.J., and Tefferi A. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 87 7 (1996) 3000-3006
8. Villamor N., Morice W.G., Chan W.C., et al. Chronic lymphoproliferative disorders of NK cells. In: Swerdlow S., Campo E., and Harris N.L. (Eds). WHO classification of tumors of haematopoietic and lymphoid tissues. 4th edition (2008), WHO press, Lyon (France) 274-275
9. Fisch P., Handgretinger R., and Schaefer H.E. Pure red cell aplasia. Br J Haematol 111 4 (2000) 1010-1022
10. Mangan K.F., Chikkappa G., and Farley P.C. Tg (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia. J Clin Invest 70 6 (1982) 1148-1156
11. Handgretinger R., Geiselhart A., Moris A., et al. Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Engl J Med 340 4 (1999) 278-284
12. Krantz S.B., and Kao V. Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. Proc Natl Acad Sci U S A 58 2 (1967) 493-500
13. Casadevall N., Nataf J., Viron B., et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 346 7 (2002) 469-475
14. Bennett C.L., Luminari S., Nissenson A.R., et al. Pure red-cell aplasia and epoetin therapy. N Engl J Med 351 14 (2004) 1403-1408
15. Bolan C.D., Leitman S.F., Griffith L.M., et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 98 6 (2001) 1687-1694
16. Mamiya S., Itoh T., and Miura A.B. Acquired pure red cell aplasia in Japan. Eur J Haematol 59 4 (1997) 199-205
17. Thompson C.A., and Steensma D.P. Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience. Br J Haematol 135 3 (2006) 405-407
18. Hirokawa M., Sawada K., Fujishima N., et al. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia. Haematologica 93 1 (2008) 27-33
19. Garcia Vela J.A., Monteserin M.C., Oña F., et al. Cyclosporine A used as a single drug in the treatment of pure red cell aplasia associated with thymoma. Am J Hematol 42 2 (1993) 238-239
20. Mangan K.F., Volkin R., and Winkelstein A. Autoreactive erythroid progenitor-T suppressor cells in the pure red cell aplasia associated with thymoma and panhypogammaglobulinemia. Am J Hematol 23 2 (1986) 167-173
21. Masuda M., Arai Y., Okamura T., et al. Pure red cell aplasia with thymoma: evidence of T-cell clonal disorder. Am J Hematol 54 4 (1997) 324-328
22. Fujishima N., Hirokawa M., Fujishima M., et al. Oligoclonal T cell expansion in blood but not in the thymus from a patient with thymoma-associated pure red cell aplasia. Haematologica 91 Suppl 12 (2006) e128-e131
23. Williamson P.J., Oscier D.G., Bell A.J., et al. Red cell aplasia in myelodysplastic syndrome. J Clin Pathol 44 5 (1991) 431-432
24. Oshimi K., Yamada O., Kaneko T., et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 7 6 (1993) 782-788
25. Hara A., Wada T., Kitajima S., et al. Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies. Am J Hematol 83 9 (2008) 750-752
26. Lai D.W., Loughran Jr. T.P., Maciejewski J.P., et al. Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia. Leuk Res 32 5 (2008) 823-827
27. Chan W.C., Foucar K., Morice W.G., et al. T-cell large granular lymphocyte leukaemia. In: Swerdlow S., Campo E., and Harris N.L. (Eds). WHO classification of tumors of haematopoietic and lymphoid tissues. 4th edition (2008), WHO Press, Lyon (France) 272-273
28. Ghazal H. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood 99 3 (2002) 1092-1094
29. Willis F., Marsh J.C.W., Bevan D.H., et al. The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol 114 4 (2001) 891-898
30. Sánchez de la Nieta M.D., Caparrós G., and Rivera F. Epoetin-induced pure red cell aplasia successfully treated with androgens. J Nephrol 19 2 (2006) 220-221
31. Clark A.D., Dessypris E., and Krantz S.B. Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 63 2 (1984) 277-286
32. Raghavachar A. Pure red cell aplasia: review of treatment and proposal for a treatment strategy. Blut 61 2-3 (1990) 47-51
33. Marmont A.M. Therapy of pure red cell aplasia. Semin Hematol 28 4 (1991) 285-297
34. Sawada K., Hirokawa M., Fujishima N., et al. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica 92 8 (2007) 1021-1028
35. Tötterman T.H., Höglund M., Bengtsson M., et al. Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effects. Eur J Haematol 42 2 (1989) 126-133
36. Cattran D.C., Greenwood C., Ritchie S., et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int 47 4 (1995) 1130-1135
37. Go R.S., Li C.Y., Tefferi A., et al. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes. Blood 98 2 (2001) 483-485
38. Dhodapkar M.V., Li C.Y., Lust J.A., et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?. Blood 84 5 (1994) 1620-1627
39. Loughran Jr. T.P., Kidd P.G., and Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 84 7 (1994) 2164-2170
40. Osuji N., Matutes E., Tjonnfjord G., et al. T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. Cancer 107 3 (2006) 570-578
41. Fujishima N., Sawada K., Hirokawa M., et al. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica 93 10 (2008) 1556-1559
42. Reinhold-Keller E., Beuge N., Latza U., et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43 5 (2000) 1021-1032
43. Talar-Williams C., Hijazi Y.M., Walther M.M., et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 124 5 (1996) 477-484
44. Lindemulder S., and Albano E. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients. Pediatrics 120 1 (2007) e47-e51
45. Thomas C.F., and Limper A.H. Pneumocystis pneumonia. N Engl J Med 350 24 (2004) 2487-2498